Ever wondered what's REALLY happening with your pharmacy data, how EU sites operate compared to the U.S., or whether you actually need $1.5M to start a research site?

In this episode of Note to File, Brad and Denali go full sticky-note mode, bouncing from European work culture to GDPR smackdowns to the future of real‑world data and AI in clinical research.

In this episode, we dig into: Copenhagen recap & EU site culture

Denali's trip to the Veeva R&D & Quality EU Summit in Copenhagen Why EU sites feel more integrated with sponsors and health systems The dominance of hospital- and health system–based sites vs. U.S. independents Why true independent sites are rarer in Europe (overhead, infrastructure, and system design) Four-day workweeks, efficiency & "wage slavery"

European 36-hour workweek norms in healthcare Do four-day weeks actually maintain productivity? Brad's reality check: embedded in clinics seeing patients 5 days a week Efficiency vs. butts-in-seats: "Do great work, then go live your life." IQVIA's GDPR fine & the illusion of anonymized data

Breakdown of the €5M GDPR fine tied to French health data warehouses Pharmacy and EMR data used for real-world evidence and analytics Why "anonymized" often… isn't Lack of transparency, consent, and real opt-outs for patients How this parallels U.S. pharmacy data being used for recruitment and targeting Consent, terms of use & contract fatigue

Are we really "consenting" when we click through IRB portals, pharmacy forms, and app updates? Contract fatigue in modern life: signing everything, reading nothing Data breaches, token identity monitoring, and what your data is apparently "worth" Site startup myths & market trends

The myth that you need $1.5M to open a site vs. Brad's "a few thousand and some hustle" Summer slowdown vs. pickup in site activity, PSVs, and study awards How the current U.S. administration and policy uncertainty ripple through the pipeline Real-world data, AI, IPOs, and whether anyone actually knows what they're building All of this wrapped in the usual unfiltered, slightly chaotic, no-agenda Note to File energy—with shoutouts, side quests, and a friendly "podcast war" declaration with Steve Wimmer's new show.